Steven Reed

CEO

Steve Reed is the Co-Founder, President, and CEO of HDT Bio Corp. His academic appointments include Professor of Medicine at Cornell University Medical College in New York and Research Professor of Pathobiology at the University of Washington. He serves on several editorial review committees, has served as a member of the Tropical Medicine Review Board of the National Institutes of Health, and is a member of the Vaccine Development Steering Committee of the World Health Organization.

Dr. Reed received a PhD in Microbiology and Immunology from the University of Montana in 1979. That year he was appointed as Scientist of the National Institute of Amazon Research in Manaus, Brazil, where he directed research on tropical diseases. He then joined Cornell University Medical College in 1980 as Assistant Professor of Medicine, continuing to work in Brazil as manager of the Cornell-Bahia program in International Medicine. He joined the Seattle Biomedical Research Institute in 1984 where he worked until founding IDRI in 1993. At IDRI he has received over $100 million in grants from the US NIH, BARDA, DARPA, and the Gates Foundation. In 1994 he co-founded Corixa Corporation (later sold to GlaxoSmithKline) serving as Chief Scientific Officer until leaving in 2004. He also founded Dharma Therapeutics, a transdermal patch company, serving as President from 2005-2008. In 2008 Dr. Reed, together with Rick Klausner, David Baltimore, and Ralph Steinman founded Immune Design Corp.(IMDZ, NASDAQ), a cancer therapeutics company, where he served as CEO until 2011.

Talks About
#biology #therapeutics

Preferred Locations
#Northamerica